Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sarepta Therapeutics

18.24
+0.04500.25%
Post-market: 18.21-0.0299-0.16%16:58 EDT
Volume:2.48M
Turnover:45.32M
Market Cap:1.79B
PE:-7.04
High:18.64
Open:18.45
Low:18.02
Close:18.20
Loading ...

Sarepta Therapeutics Exec Says Co Hasn't yet Identified a Single Risk Factor Related to the Therapy

THOMSON REUTERS
·
16 Jun

Sarepta Therapeutics Cut to Sell From Neutral by HC Wainwright & Co.

Dow Jones
·
16 Jun

5 Things to Know Before the Stock Market Opens

Investopedia
·
16 Jun

Pre-Bell|U.S. Futures Rise; Crypto Stocks Shine; Tesla and Palantir Gain 2%; U.S. Steel Jumps 5%; Sarepta Tanks 38%

Tiger Newspress
·
16 Jun

BUZZ-U.S. STOCKS ON THE MOVE-EchoStar, T1 Energy, Smurfit Westrock

Reuters
·
16 Jun

BMO Capital Downgrades Sarepta Therapeutics to Market Perform From Outperform, Adjusts PT to $70 From $120

MT Newswires Live
·
16 Jun

Sarepta Therapeutics Inc : Bmo Cuts to Market Perform From Outperform; Cuts Target Price to $70 From $120

THOMSON REUTERS
·
16 Jun

Sarepta Therapeutics Inc : H.c. Wainwright Cuts to Sell From Neutral

THOMSON REUTERS
·
16 Jun

Sarepta downgraded to Sell from Neutral at H.C. Wainwright

TIPRANKS
·
16 Jun

Sarepta Therapeutics, Inc. : H.c. Wainwright Cuts Target Price to $10 From $40

THOMSON REUTERS
·
16 Jun

U.S. Stocks to Watch: Sarepta, Tesla, Circle, SharpLink, Palantir, XPeng, Nvidia and More

Dow Jones
·
16 Jun

Sarepta Therapeutics Maintains Buy Rating Amid Proactive Safety Measures for Elevidys Treatment

TIPRANKS
·
16 Jun

Sarepta Therapeutics: Buy Rating Affirmed Amid Strategic Safety Measures and Long-Term Potential

TIPRANKS
·
16 Jun

Stocks to Watch: Victoria's Secret, Renault, U.S. Steel, Sarepta -- WSJ

Dow Jones
·
16 Jun

Stock Track | Sarepta Therapeutics Plunges 31.76% Pre-market on Second Fatal Liver Failure Case and Suspended Shipments

Stock Track
·
16 Jun

U.S. RESEARCH ROUNDUP- Hinge Health, Packaging Corp of America, Zscaler

Reuters
·
16 Jun

Sarepta Therapeutics Shares Down 26.9% After Co Reports Second Case of Liver Failure Death After Its Gene Therapy Treatment

THOMSON REUTERS
·
16 Jun

Sarepta Reports Second Case Of Liver Failure Death After Its Gene Therapy Treatment

Reuters
·
16 Jun

Sarepta Therapeutics Inc : Piper Sandler Cuts to Neutral From Overweight; Cuts Target Price to $36.00 From $70.00

THOMSON REUTERS
·
16 Jun

Cautious Outlook on Sarepta Therapeutics Amid Elevidys Safety Concerns and Regulatory Uncertainty

TIPRANKS
·
16 Jun